118 related articles for article (PubMed ID: 6400112)
1. Cerebrovascular effects of the converting enzyme inhibitor captopril.
Jarden JO; Barry DI; Strandgaard S; Graham DI; Paulson OB
J Hypertens Suppl; 1983 Dec; 1(2):126-8. PubMed ID: 6400112
[TBL] [Abstract][Full Text] [Related]
2. Converting enzyme inhibition and autoregulation of cerebral blood flow in spontaneously hypertensive and normotensive rats.
Strandgaard S; Barry DI; Paulson OB
Scand J Urol Nephrol Suppl; 1984; 79():35-8. PubMed ID: 6089316
[TBL] [Abstract][Full Text] [Related]
3. Acute sympathetic denervation does not eliminate the effect of angiotensin converting enzyme inhibition on CBF autoregulation in spontaneously hypertensive rats.
Waldemar G
J Cereb Blood Flow Metab; 1990 Jan; 10(1):43-7. PubMed ID: 2404998
[TBL] [Abstract][Full Text] [Related]
4. Captopril treatment temporarily restores cerebral blood flow autoregulation in spontaneously hypertensive rats after hemorrhagic stroke.
Davis LA; Smeda JS
J Cardiovasc Pharmacol; 2010 Sep; 56(3):255-62. PubMed ID: 20531216
[TBL] [Abstract][Full Text] [Related]
5. Captopril improves cerebrovascular structure and function in old hypertensive rats.
Dupuis F; Atkinson J; Limiñana P; Chillon JM
Br J Pharmacol; 2005 Feb; 144(3):349-56. PubMed ID: 15655534
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibition and the upper limit of cerebral blood flow autoregulation: effect of sympathetic stimulation.
Waldemar G; Paulson OB; Barry DI; Knudsen GM
Circ Res; 1989 Jun; 64(6):1197-204. PubMed ID: 2655965
[TBL] [Abstract][Full Text] [Related]
7. Converting enzyme inhibition resets cerebral autoregulation at lower blood pressure.
Paulson OB; Vorstrup S; Andersen AR; Smith J; Godtfredsen J
J Hypertens Suppl; 1985 Dec; 3(3):S487-8. PubMed ID: 2856774
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme inhibition and cerebral blood flow autoregulation in normotensive and hypertensive man.
Waldemar G; Schmidt JF; Andersen AR; Vorstrup S; Ibsen H; Paulson OB
J Hypertens; 1989 Mar; 7(3):229-35. PubMed ID: 2540235
[TBL] [Abstract][Full Text] [Related]
9. No effect of angiotensin II AT(2)-receptor antagonist PD 123319 on cerebral blood flow autoregulation.
Estrup TM; Paulson OB; Strandgaard S
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):188-92. PubMed ID: 11881121
[TBL] [Abstract][Full Text] [Related]
10. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
11. Cerebral blood flow (CBF) autoregulation in spontaneously hypertensive rats (SHR) during chronic administration of a theophylline derivative (P-23).
Kozłowska T; Olejnik A; Krawczak J; Chodera A; Barry D; Pedersen E
Pol J Pharmacol Pharm; 1989; 41(6):611-8. PubMed ID: 2518576
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation.
Vraamark T; Waldemar G; Strandgaard S; Paulson OB
J Hypertens; 1995 Jul; 13(7):755-61. PubMed ID: 7594439
[TBL] [Abstract][Full Text] [Related]
13. Ceranapril and cerebral blood flow autoregulation.
Torup M; Waldemar G; Paulson OB
J Hypertens; 1993 Apr; 11(4):399-405. PubMed ID: 8390507
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats.
Januszewicz A; Lapiński M; Styś T; Styś A; Loń S
Pol J Pharmacol; 1994; 46(3):153-61. PubMed ID: 8000447
[TBL] [Abstract][Full Text] [Related]
15. Attenuation and recovery of brain stem autoregulation in spontaneously hypertensive rats.
Toyoda K; Fujii K; Ibayashi S; Kitazono T; Nagao T; Takaba H; Fujishima M
J Cereb Blood Flow Metab; 1998 Mar; 18(3):305-10. PubMed ID: 9498847
[TBL] [Abstract][Full Text] [Related]
16. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
Guidi E; Hollenberg NK
J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
[TBL] [Abstract][Full Text] [Related]
17. Effects of captopril on cerebral blood flow in normotensive and hypertensive rats.
Barry DI; Paulson OB; Jarden JO; Juhler M; Graham DI; Strandgaard S
Am J Med; 1984 May; 76(5B):79-85. PubMed ID: 6328989
[TBL] [Abstract][Full Text] [Related]
18. Cerebrovascular aspects of converting-enzyme inhibition II: Blood-brain barrier permeability and effect of intracerebroventricular administration of captopril.
Jarden JO; Barry DI; Juhler M; Graham DI; Strandgaard S; Paulson OB
J Hypertens; 1984 Dec; 2(6):599-604. PubMed ID: 6098609
[TBL] [Abstract][Full Text] [Related]
19. [The effect of captopril on cerebral blood flow in hypertensive rats before and after cerebral ischemia].
Adzhienko LM
Eksp Klin Farmakol; 1999; 62(5):18-20. PubMed ID: 10572745
[TBL] [Abstract][Full Text] [Related]
20. Effects of the angiotensin I converting enzyme inhibitor perindopril on cerebral blood flow in awake hypertensive rats.
Bray L; Lartaud I; Muller F; Atkinson J; Capdeville C
Am J Hypertens; 1991 Mar; 4(3 Pt 2):246S-252S. PubMed ID: 2043313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
